A method for the preparation of stable and water-soluble analogs of low density lipoprotein (LDL) is presented. The experimental protocols start with the preparation of a cholesteryl ester/phospholipid microemulsion by a combined injection-sonication procedure and delipidation of apoprotein B (apoB) with sodium deoxycholate (NaDOC). The association of lipid microemulsion and NaDOC-solubilized apoB is achieved by incubation and sonication of the components above the melting point of the cholesteryl ester. The reconstituted model LDL (m-LDL) proved to be quite homogeneous both with respect to particle size and composition. Negative-stain electron microscopy shows spherical particles with a mean diameter of 21 nm. The mean density of the reconstituted LDL was 1.07 g/ml as determined by sucrose density gradient centrifugation. The reconstituted LDL retained its beta-mobility on agarose gel electrophoresis, and sodium dodecyl sulfate (SDS)-gel electrophoresis showed no degradation of apoB during the reconstitution procedures. Studies of biological activity showed that the m-LDL particles are bound, incorporated, and degraded by human fibroblasts in a way similar to native LDL. The reconstituted m-LDL has potential use for metabolic, physiochemical, and enzymatic studies of lipoproteins.
No takes yet. Share an insight, caveat, or question.
Lundberg et al. (1984) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: